grant

Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents

Organization DIVISION OF BASIC SCIENCES - NCILocation UNITED STATES
NIHUS FederalResearch GrantFY20255-IsothiocyanatofluoresceinActive Follow-upAffinityAlkynesAnti-Cancer AgentsAntibiotic AgentsAntibiotic DrugsAntibioticsAntineoplastic AgentsAntineoplastic DrugsAntineoplasticsAssayAzidesAzolesBindingBioassayBiologicalBiological AssayC-terminalCancer DrugCancersCell Communication and SignalingCell CycleCell Division CycleCell SignalingCephalosporinsComplexComputer softwareCopperCu elementDNADNA Nicking-Closing ProteinDNA Relaxing EnzymeDNA Relaxing ProteinDNA Repair EnzymesDNA Topoisomerase IDNA TopoisomerasesDNA Type 1 TopoisomeraseDNA Untwisting EnzymeDNA Untwisting ProteinDeoxyribonucleic AcidDigitDigit structureDockingE3 LigaseE3 Ubiquitin LigaseELISAEnzyme-Linked Immunosorbent AssayFITCFamilyFluoresceinFluorescein-5-isothiocyanateFluorescenceFluorescence PolarizationFluorescent ProbesFoundationsGelH-bondHistidineHydrogen BondingIntracellular Communication and SignalingKinasesL-SerineL-ThreonineLabelLeadLecithinase DLengthLibrariesLigand BindingLigandsMalignant NeoplasmsMalignant TumorMeasuresMiscellaneous AntibioticModelingModificationMolecular InteractionMolecular TargetN-terminalNH2-terminalNeoplastic Disease Chemotherapeutic AgentsNitrogenPLK GenePLK1PLK1 genePTK InhibitorsParentsPb elementPenicillin-Binding ProteinsPeptidesPhosphatesPhosphatidylcholine PhosphohydrolasePhospholipase DPhosphorylserinePhosphoserinePhosphothreoninePhosphotransferase GenePhosphotransferasesPolo-Box DomainPolo-Like KinaseProtacProtein Tyrosine Kinase InhibitorsProteinsProteolysis targeting chimericReactionReportingSTPK13SeriesSerineSerine PhosphateSerine/Threonine Protein Kinase 13Seryl PhosphateSideSignal TransductionSignal Transduction SystemsSignalingSoftwareStructureSurface Plasmon ResonanceTK InhibitorsThreonineThreonine PhosphateTopoisomeraseTopoisomerase ITopoisomerase InhibitorsTransphosphorylasesTumor-Specific Treatment AgentsType I DNA TopoisomerasesTyr-DNA phosphodiesteraseTyrosineTyrosine Kinase InhibitorUbiquitin Protein LigaseUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligase E3Workactive followupanti-canceranti-cancer drugbeta lactam antibioticbeta-Lactamsbiologicbiological signal transductioncovalent bondcycloadditiondesigndesigningenzyme linked immunoassayflexibilityflexiblefollow upfollow-upfollowed upfollowupheavy metal Pbheavy metal leadimprovedinhibitorinorganic phosphatelipophosphodiesterase IImalignancymemberneoplasm/cancernew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnicking closing enzymenovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyoverexpressoverexpressionparentpharmacophorephosphatidylcholine phosphatidohydrolasephosphodiesterpolo-like kinase 1protein protein interactionproteolysis targeting chimaeraproteolysis targeting chimerarelaxing enzymesmall moleculespatial and temporalspatial temporalspatiotemporalswivelasetumortyrosyl-DNA phosphodiesteraseubiquitin-protein ligaseuntwisting enzymeuptakevirtualwortmanninβ lactam antibioticβ-Lactams
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Objective One: Plk1 is composed of an N-terminal catalytic kinase domain (KD) and a C-terminal polo-box domain (PBD). The PBD recognizes phosphoserine (pS) and phosphothreonine (pT)-containing sequences, facilitating protein-protein interactions (PPIs). The KD is tethered to the PBD by means of a flexible interdomain linker. Intramolecular…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Inhibitors of Tyrosine Kinase-Dependent Signaling as Anti-Cancer Agents — DIVISION OF BASIC SCIENCES - NCI | UNITED STAT | Dev Procure